Clariane SE

As of June 30, 2026, Clariane SE carries a market capitalization of 1.49B, placing it among publicly traded companies globally. Its enterprise value stands at 8.72B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Clariane SE's next confirmed earnings release is scheduled for March 4, 2027.

As of June 30, 2026, Clariane SE has 357.29M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Clariane SE maintains a current ratio of 0.84, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Clariane SE's stock has declined approximately 25.92% over the past 52 weeks. The 50-day moving average sits at 3.75, while the 200-day moving average is 3.90.

As of June 30, 2026, Clariane SE holds 1.41B in cash and equivalents against 8.35B in total debt, resulting in a net debt position of 3.02B. Total book value stands at 3.62B, with working capital of -445.65M providing operational flexibility.

Clariane SE's most recent stock split took place on June 14, 2024 with a 860:1379 split ratio.